Addex

Allosteric modulators for human health

  • About us
    • Addex Corporate Presentation
    • Overview
    • Our people
      • Executive Officers
      • Non-Executive Directors
      • Scientific Advisory Board
    • Contact
    • Privacy Policy
    • Careers
  • Pipeline
    • Clinical and Pre-Clinical Pipeline
    • Research And Development
  • Technology platform
    • Allosteric modulation
    • Our capabilities
      • Screening Assays
      • Chemistry
    • Publications
  • Partners & collaboration
  • Investors
    • Addex Corporate Presentation
    • Stock Data
    • Press releases
    • Ad hoc announcements (Art. 53 L.R)
    • Events
    • Financial Reports
    • Analyst Reports
    • General Meetings
    • SEC / SIX Filings
    • Guide to US ADSS for Six Shareholders
    • Register for email news
    • Corporate Governance
    • Contact
  • Media
    • Press releases
    • Contact

Analyst Reports

  • Van Leewenhoeck Jul-2020
  • Van Leewenhoeck Dec-2019
  • Van Leewenhoeck Aug-2019
  • Van Leewenhoeck Nov-2018
  • Van Leewenhoeck Jul-2018
  • Van Leewenhoeck Feb-2018
  • ValuationLAB Jan-2018
  • Van Leewenhoeck Oct-2017 
2023 © Addex therapeutics